Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), have found a potential path to maintaining the cancer-fighting benefits of ...

Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the listing of Minjuvi® (tafasitamab), in combination with rituximab and lenalidomide, on the Pharmaceutical ...

Patients with bone metastasis had a lower risk of death with immunotherapy alone or with immunotherapy plus surgery than with surgery alone. The survival benefits observed with different treatments ...

This newer mode of administration for immunotherapy comes with benefits and risks. It is important for a person to work with a doctor when making treatment decisions for upper gastrointestinal (GI) ...

Targeted therapy and immunotherapy have transformed cancer treatment, but they work in very different ways. A medical ...

A new drug could offer a powerful way to sensitise tumours to immunotherapy, a new trial suggests. Ceralasertib showed promise for patients no longer responding to current cancer treatments in an ...

AlloCAR70-NKT is an off-the-shelf immunotherapy using engineered immune cells to target kidney cancer without patient-specific customization. The therapy addresses challenges of traditional CAR-T ...

Immunotherapy is a type of cancer treatment that stimulates a patient's immune system to attack tumors. While promising, its effectiveness varies among patients. The new VUB technology helps identify ...